dr anna chacon semaglutide Dr. Chacon, A Leader in Modern Dermatology Innovation, in Ejecutiva Magazine Dr. Anna Chacon, MD FAAD

Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications

A higher-dose version of semaglutide, called Wegovy, is FDA-approved specifically for long-term weight management in people with obesity and certain health conditions

Longer term follow-up from the cohorts (and when feasible RCTs) will be important to avoid underestimating the true long-term risks for harm

Multinational internet-based survey of patient preference for newer oral or injectable type 2 diabetes medication

Studies show that with long-term use, people can maintain this weight loss for years, though you need to continue to take the medication

Less-Common Side Effects The following effects are reported less frequently but are worth understanding before and during treatment